Skip to Main Content

Paper Details

Genomic and transcriptomic characterization of skull base chordoma.
Oncotarget
15
2017
-SASH1, 1p, MUC4, NBPF1, NPIPB15, NPIPB15 mutations, SAMD5, SASH1, Skull base chordoma, T, T gene, chordoma, germline SNP, malignant bone-origin tumor, rs2305089, skull base chordoma, skull base chordomas
Aged, Base Sequence, Chordoma, Female, Fetal Proteins, Genomics, Humans, Male, Middle Aged, Skull Base Neoplasms, T-Box Domain Proteins, Transcriptome
Author NameAffiliation
Jason K SaSamsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University
Jason K SaSamsung Biomedical Research Institute, Samsung Medical Center
Jason K SaInstitute for Refractory Cancer Research, Samsung Medical Center
In-Hee LeeSamsung Biomedical Research Institute, Samsung Medical Center
In-Hee LeeInstitute for Refractory Cancer Research, Samsung Medical Center
In-Hee LeeSamsung Biomedical Research Institute, Samsung Medical Center
In-Hee LeeInstitute for Refractory Cancer Research, Samsung Medical Center
Sang Duk HongSamsung Medical Center, Sungkyunkwan University School of Medicine
Doo-Sik KongSamsung Biomedical Research Institute, Samsung Medical Center
Doo-Sik KongSamsung Medical Center, Sungkyunkwan University School of Medicine
Doo-Sik KongInstitute for Refractory Cancer Research, Samsung Medical Center
Doo-Sik KongSamsung Biomedical Research Institute, Samsung Medical Center
Doo-Sik KongInstitute for Refractory Cancer Research, Samsung Medical Center
Doo-Sik KongSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University
Do-Hyun NamSamsung Biomedical Research Institute, Samsung Medical Center
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Advanced Institute for Health Science & Technology (SAIHST), Sungkyunkwan University
Do-Hyun NamSamsung Biomedical Research Institute, Samsung Medical Center
Do-Hyun NamInstitute for Refractory Cancer Research, Samsung Medical Center
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
  • 1 - 22

Datasets

Release 1.2